↓ Skip to main content

Modulation of inflammation and angiogenesis and changes in ECM GAG-activity via dual delivery of nucleic acids

Overview of attention for article published in Clinical Materials, August 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Modulation of inflammation and angiogenesis and changes in ECM GAG-activity via dual delivery of nucleic acids
Published in
Clinical Materials, August 2015
DOI 10.1016/j.biomaterials.2015.08.012
Pubmed ID
Authors

Shane Browne, Michael G. Monaghan, Eva Brauchle, Daniel Carvajal Berrio, Sandrine Chantepie, Dulce Papy-Garcia, Katja Schenke-Layland, Abhay Pandit

Abstract

Tissue-engineered organs and implants hold promise for the replacement of damaged and diseased organs. However, the foreign body response (FBR) is a major obstacle that compromises the function of tissue-engineered constructs, typically causing them to fail. Two components of FBR are an inflammatory response and a lack of vascularization. To overcome these limitations, a collagen system was developed to release interleukin-6 (IL-6) siRNA and endothelial nitric oxide synthase (eNOS) pDNA in a staggered manner. Hollow collagen microspheres were assembled into a collagen sphere-in-hydrogel system that displayed a staggered release profile in vitro. This system was assessed in vivo in a subcutaneous rat model. The doses of IL-6 siRNA and eNOS pDNA were first individually optimized for their ability to reduce the volume fraction of inflammatory cells (7 days) and increase the length density of blood vessels (14 days), respectively. The identified optimal doses were combined, and the ability of the system to decrease the volume fraction of inflammatory cells and increase the length density of blood vessels was confirmed at both 7 and 14 days. Analysis of the tissue using Raman microspectroscopy revealed that in addition to changes in inflammation and angiogenesis, there were also changes in the extracellular matrix (ECM) at seven days. While changes in sulfated glycosaminoglycan (sGAG) content of the ECM were not detected, changes in the binding of sGAG of the ECM to growth factors were observed. Two growth factors tested, VEGF165 and bFGF showed increased binding to sGAG extracted from eNOS pDNA-treated samples at seven days, increasing the angiogenic potential of the ECM. Thus, we observe that changes in the tissue in terms of the balance of inflammation and angiogenesis as well changes in the activity of sGAG of the ECM occurs following dual delivery of nucleic acids from the collagen sphere-in-hydrogel system.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Ireland 1 2%
Unknown 55 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 25%
Student > Ph. D. Student 11 19%
Student > Bachelor 4 7%
Researcher 4 7%
Other 4 7%
Other 10 18%
Unknown 10 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 19%
Agricultural and Biological Sciences 8 14%
Materials Science 6 11%
Engineering 5 9%
Medicine and Dentistry 5 9%
Other 7 12%
Unknown 15 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2015.
All research outputs
#4,858,208
of 25,461,852 outputs
Outputs from Clinical Materials
#2,031
of 10,771 outputs
Outputs of similar age
#55,868
of 275,667 outputs
Outputs of similar age from Clinical Materials
#24
of 108 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,771 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,667 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.